FDA Inspection 1162560 — Dominik Dahl
The FDA completed an inspection of Dominik Dahl on Jan 28, 2022 in Hamburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 28, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hamburg (Germany)
Additional Details
Clinical Investigator (CI)